| Stage | CHRD | % of rev | EOG | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $2.2B | 100.00% | $8.6B | 100.00% | EOG ×3.94 |
| Gross profit | $1.4B | 66.20% | $7.4B | 86.65% | EOG +20.5pp |
| Operating income | $603M | 27.74% | $3.5B | 41.21% | EOG +13.5pp |
| Pre-tax income | $687M | 31.63% | $3.5B | 40.87% | EOG +9.2pp |
| Net income | $525M | 24.17% | $2.7B | 31.81% | EOG +7.6pp |
| Stage | CHRD | EOG | Gap · A − B |
|---|---|---|---|
| Revenue | $2.2B100.00% | $8.6B100.00% | EOG ×3.94 |
| Gross profit | 66.20%$1.4B | 86.65%$7.4B | EOG +20.5pp |
| Operating income | 27.74%$603M | 41.21%$3.5B | EOG +13.5pp |
| Pre-tax income | 31.63%$687M | 40.87%$3.5B | EOG +9.2pp |
| Net income |
| 24.17%$525M |
| 31.81%$2.7B |
| EOG +7.6pp |
No shared counterparties.